EP Patent

EP3675868A1 — Testosterone ester triglyceride formulations

Assigned to Antares Pharma Inc · Expires 2020-07-08 · 6y expired

What this patent protects

The invention relates to testosterone ester triglyceride formulations, optionally further comprising adducts. The invention also relates to methods of in situ control of the manufacture or formation of such adducts.

USPTO Abstract

The invention relates to testosterone ester triglyceride formulations, optionally further comprising adducts. The invention also relates to methods of in situ control of the manufacture or formation of such adducts.

Drugs covered by this patent

Patent Metadata

Patent number
EP3675868A1
Jurisdiction
EP
Classification
—
Expires
2020-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Antares Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.